Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (22) Caverject (alprostadil), Upjohn,
...Newly Approved Drug Therapies (22) Caverject (alprostadil), Upjohn, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Caverject (alprostadil) Company: Upjohn Approval Status: Approved on July 6, 1995 Treatment Area: impotence General Information Caverject ...
View Page

2.  Newly Approved Drug Therapies (273) EDEX, Schwarz Pharma,
...Company: Schwarz Pharma Approval Status: Approved June 1997 Treatment Area: erectile dysfunction General Information EDEX (alprostadil for injection) has been approved for the treatment of male erectile dysfunction, which affects more ...
View Page

3.  Newly Approved Drug Therapies (171) Muse, Vivus,
...the treatment of impotence. Mechanism of Action Muse is a single-use disposable applicator containing alprostadil, a synthetic version of the naturally occurring vasodilator prostaglandin E1. Jobson Medical Information • Privacy | • Glossary ...
View Page

4.  CenterWatch: New Medical Therapies in Disease Category (333), Sexual Dysfunction
...are ongoing. May 30, 2005 NexMed issued positive results of a clinical trial of Femprox (alprostadil) , for the treatment of female sexual arousal disorder (FSAD), at the Annual Meeting of the ...
...results. July 19, 2004 Vivus announced the data from their phase II study of Alista (alprostadil) , their topical gel for the treatment of Female Sexual Arousal Disorder (FSAD). Analysis showed that ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (123), Premature Ejaculation
...and placebo groups. April 28, 2003 NexMed reported positive results from a pilot study investigating alprostadil/lidocaine/NexACT , a topical cream combination for the treatment of premature ejaculation (PE). The primary ...
View Page

6.  CenterWatch: Nephrology/Urology Approved Drug Therapies
...implant) ; AstraZeneca; Treatment for advanced prostate cancer, Approved January 1996 Drugs Approved in 1995 Caverject (alprostadil) ; Upjohn; Treatment for impotence, Approved on July 6, 1995 Jobson Medical Information • Privacy | • Glossary Copyright ...
View Page

7.  CenterWatch: List of Newly Approved Drug Thearapies
...tablets) ; Wyeth; Treatment for postmenopausal hormone replacement, postmenopausal osteoporosis, Approved November 1995 Nephrology/Urology Caverject (alprostadil) ; Upjohn; Treatment for impotence, Approved on July 6, 1995 Neurology Avonex (Interferon Beta 1-A ...
View Page

8.  CenterWatch: New Medical Therapies in Disease Category (371), Erectile Dysfunction
...syncope. NexMed reported positive results from two pivotal phase III trials investigating Alprox-TD , a alprostadil transdermal cream for the treatment of erectile dysfunction (ED). Results demonstrated that the three dose ...
View Page